ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $15,247,000 | -20.1% | 1,225,891 | -12.1% | 0.01% | -7.7% |
| Q3 2016 | $19,082,000 | +167.3% | 1,394,077 | +44.2% | 0.01% | +160.0% |
| Q2 2016 | $7,138,000 | +41.0% | 966,454 | +21.9% | 0.01% | +25.0% |
| Q1 2016 | $5,064,000 | +201.4% | 792,836 | +194.7% | 0.00% | +300.0% |
| Q4 2015 | $1,680,000 | +24.4% | 269,006 | +16.0% | 0.00% | 0.0% |
| Q3 2015 | $1,351,000 | -77.5% | 231,817 | -68.1% | 0.00% | -75.0% |
| Q2 2015 | $6,010,000 | -36.5% | 727,033 | -36.8% | 0.00% | -33.3% |
| Q1 2015 | $9,471,000 | +809.8% | 1,149,750 | +656.7% | 0.01% | +500.0% |
| Q4 2014 | $1,041,000 | +31.3% | 151,948 | +3.2% | 0.00% | – |
| Q3 2014 | $793,000 | -88.2% | 147,199 | -86.1% | 0.00% | -100.0% |
| Q2 2014 | $6,747,000 | -35.1% | 1,059,740 | -17.9% | 0.01% | -28.6% |
| Q1 2014 | $10,392,000 | +413.7% | 1,291,555 | +333.4% | 0.01% | +600.0% |
| Q4 2013 | $2,023,000 | -93.9% | 297,998 | -83.5% | 0.00% | -96.0% |
| Q3 2013 | $33,237,000 | – | 1,807,924 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |